Uses of TSYI-PA102 to improve osteoarthritis
Cordyceps militaris strain TSYI-PA102 compositions effectively address osteoarthritis by reducing inflammation and slowing disease progression, providing a safe and effective treatment option.
TWI934428BPending Publication Date: 2026-08-01SYI BIOTECH CO LTD
1 Cites 0 Cited by
Patent Information
- Application Number
- TW114102558
- Authority / Receiving Office
- TW · TW
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2025-01-21
- Publication Date
- 2026-08-01
- Estimated Expiration
- 2045-01-20
AI Technical Summary
Technical Problem
Current treatments for osteoarthritis primarily focus on symptom relief and cannot effectively improve or slow the progression of the disease, and existing drugs have undesirable side effects.
Method used
The use of Cordyceps militaris strain TSYI-PA102 in compositions to improve osteoarthritis, which includes deep-culture products, reducing inflammatory indices like IL-1β, IL-6, and TNF-α, and administering effective doses ranging from 66 mg/kg to 264 mg/kg body weight.
Benefits of technology
Cordyceps militaris TSYI-PA102 compositions significantly reduce osteoarthritis symptoms and inflammatory markers, offering a safe and effective strategy to improve or delay the disease progression.
✦ Generated by Eureka AI based on patent content.
Abstract
This invention provides the use of Cordyceps militaris strain TSYI-PA102 for improving osteoarthritis, the accession number of which is BCRC 930232; osteoarthritis can be improved by applying Cordyceps militaris TSYI-PA102.
Need to check novelty before this filing date? Find Prior Art